Metabolomics research of AREDS2 data
Ended Purchase Order Awarded Last action
- Contract number
- 75N98021P02397
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,732,236
Award facts
- Opportunity
-
- Metabolomics Evaluation of the Age-Related Eye Disease Study 2 (AREDS2) Special Notice · 75N98021P02397 · Posted Aug 13, 2021
- Contract value 100% obligated
- $1,732,236.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Eye Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Morrisville, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $749,995 | |
| Funding Only Action | $500,000 | |
| Other Administrative Action | $0 | |
| Original award | $482,241 |
About this award
The National Institutes of Health, on behalf of the National Eye Institute, awarded Metabolon, Inc. a $1.7 million firm fixed price purchase order to conduct metabolomics research of approximately 2,001 serum samples from the Age-Related Eye Disease Study 2 clinical trial. Metabolon will identify over 1,000 metabolites in the samples, map them to biological pathways, and perform data processing, quality control, and preliminary statistical analysis to identify metabolites associated with age-related macular degeneration. This contract is being awarded through a Special Notice solicitation to leverage Metabolon's unique capabilities and capacity to complete the metabolomics evaluation within the required 12-month period of performance using the available 150 microliter biospecimens. Deliverables include providing final data to NIH and NCATS upon completion.
Quick answers
Who was awarded contract 75N98021P02397?
75N98021P02397 was awarded to Metabolon, Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 7, 2021.
How much is contract 75N98021P02397 worth?
The government has obligated $1,732,236 on 75N98021P02397.
Which agency awarded contract 75N98021P02397?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98021P02397, with funding from National Eye Institute (National Institutes of Health).
Was contract 75N98021P02397 competed?
The extent of competition for 75N98021P02397 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award